mTOR inhibitor monotherapy. A good treatment choice in renal transplantation?

Statistics

Monoterapia m-TOR. ¿Una buena elección en trasplante renal?

antonio Franco Estevea, Antonio Franco-Esteveb, diana torderaa, Diana Torderab, maria luz de la senc, M. Luz De la send, luis Jiméneza, Luis Jiménezb, patricio Mase, Patricio Masf, carlos muñozg, Carlos Muñozd, jesus olivaresa, Jesús Olivaresb

a Unidad de Nefrología, Hospital General de Alicante, Alicante, Spain,

b Unidad de Nefrología, Hospital General de Alicante, Alicante,

c Unidad deinmunologia, Hospital General de Alicante, Alicante, Spain,

d Unidad de Inmunología, Hospital General de Alicante, Alicante,

e Departamento de Farmacología, Hospital General de Alicante, Alicante, Spain,

f Departamento de Farmacología, Hospital General de Alicante, Alicante,

g Servicio de Inmunología, Hospital General de Alicante, Alicante, Spain,

Read

12297

Times
was read the article

2873

Total PDF

9424

Total HTML

Share statistics

Article information

ISSN: 20132514
Original language: English

DOI:10.3265/Nefrologia.pre2012.Jun.11314

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 6	53	40	93
2025 5	134	61	195
2025 4	86	36	122
2025 3	143	66	209
2025 2	122	45	167
2025 1	103	34	137
2024 12	89	36	125
2024 11	71	59	130
2024 10	65	40	105
2024 9	73	35	108
2024 8	71	58	129
2024 7	68	36	104
2024 6	88	41	129
2024 5	75	42	117
2024 4	78	28	106
2024 3	62	33	95
2024 2	38	44	82
2024 1	58	24	82
2023 12	46	22	68
2023 11	64	32	96
2023 10	55	41	96
2023 9	39	28	67
2023 8	70	29	99
2023 7	56	27	83
2023 6	44	29	73
2023 5	69	31	100
2023 4	28	21	49
2023 3	39	26	65
2023 2	47	21	68
2023 1	40	22	62
2022 12	106	26	132
2022 11	80	32	112
2022 10	54	53	107
2022 9	46	32	78
2022 8	58	53	111
2022 7	42	41	83
2022 6	56	44	100
2022 5	60	35	95
2022 4	53	48	101
2022 3	62	51	113
2022 2	47	46	93
2022 1	49	30	79
2021 12	60	48	108
2021 11	41	34	75
2021 10	52	46	98
2021 9	34	42	76
2021 8	54	40	94
2021 7	50	28	78
2021 6	34	22	56
2021 5	55	34	89
2021 4	63	79	142
2021 3	53	36	89
2021 2	65	20	85
2021 1	43	23	66
2020 12	46	17	63
2020 11	57	16	73
2020 10	46	18	64
2020 9	25	11	36
2020 8	46	9	55
2020 7	35	14	49
2020 6	43	18	61
2020 5	56	13	69
2020 4	36	19	55
2020 3	35	9	44
2020 2	43	20	63
2020 1	61	18	79
2019 12	78	20	98
2019 11	63	22	85
2019 10	53	11	64
2019 9	63	30	93
2019 8	60	26	86
2019 7	70	20	90
2019 6	68	23	91
2019 5	50	15	65
2019 4	101	27	128
2019 3	46	19	65
2019 2	58	19	77
2019 1	62	24	86
2018 12	114	44	158
2018 11	84	11	95
2018 10	107	9	116
2018 9	90	9	99
2018 8	53	18	71
2018 7	63	9	72
2018 6	54	13	67
2018 5	68	9	77
2018 4	67	13	80
2018 3	79	12	91
2018 2	59	9	68
2018 1	51	5	56
2017 12	64	11	75
2017 11	80	17	97
2017 10	68	8	76
2017 9	65	13	78
2017 8	33	11	44
2017 7	57	13	70
2017 6	55	11	66
2017 5	72	12	84
2017 4	41	12	53
2017 3	69	24	93
2017 2	91	17	108
2017 1	59	17	76
2016 12	80	12	92
2016 11	164	11	175
2016 10	163	10	173
2016 9	346	9	355
2016 8	296	18	314
2016 7	237	18	255
2016 6	195	0	195
2016 5	186	0	186
2016 4	158	0	158
2016 3	116	0	116
2016 2	164	0	164
2016 1	153	0	153
2015 12	158	0	158
2015 11	128	0	128
2015 10	138	0	138
2015 9	102	0	102
2015 8	86	0	86
2015 7	103	0	103
2015 6	48	0	48
2015 5	63	0	63
2015 4	5	0	5

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter